-transparent.png){kind=logo}
The value of glycosylated hemoglobin (HbA1) has been determined in diabetic patients with simple or proliferative retinopathy and in those without retinopathy. The mean value of HbA1 is significantly more highly elevated in patients with retinopathy than in those without retinopathy. Progressive augmentation of the value of HbA1 signifies a risk of deterioration of the retinopathy, whether it is a simple retinopathy or proliferative retinopathy.
Related Publications
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
August 1991,
Annals of ophthalmology,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
August 1980,
Annals of internal medicine,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
November 1988,
JAMA,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
July 2004,
Indian journal of clinical biochemistry : IJCB,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
July 2008,
Diabetes research and clinical practice,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
March 1980,
Annals of internal medicine,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
March 1984,
Journal of manipulative and physiological therapeutics,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
May 2011,
Diabetes research and clinical practice,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
August 1976,
The New England journal of medicine,
T Harada, and
Y Tanabe, and
K Kojima, and
K Harada
July 1981,
Diabetes,
